InpharmD vs ManageAnticoag
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
InpharmD
Access on-demand digital drug information tailored for healthcare providers. This app promotes evidence-based medicine by saving time and resources.
- On-demand digital drug information
- Tailored information for providers
- Promotes evidence-based medicine
- Saves time and resources
Read full descriptionHide full description
We save time and resources for healthcare providers by providing tailored, on demand, digital drug information, in order to promote evidence-based medicine.
ManageAnticoag
This clinical decision support tool assists healthcare professionals in managing patients on oral anticoagulants. It provides guidance on interrupting anticoagulation, managing acute bleeds, and restarting treatment. Clinicians can input patient details to receive individualized advice and access supporting information.
- Periprocedural planning for OAC patients
- Bleed management guidance
- Anticoagulation interruption and bridging advice
- Reversal agent suggestions
- Anticoagulation restart determination
- Quick Reference section for supporting information
Read full descriptionHide full description
This clinical decision support app helps clinicians navigate periprocedural planning and bleed management scenarios for patients on oral anticoagulants (OAC). The app is comprised of three tools to support the following clinical decisions: • Assessing whether and how to interrupt and bridge anticoagulation • Managing acute bleeds, including the suggested use of reversal agents • Determining whether and how anticoagulation should be restarted A clinician can use the app by: • Selecting which tool best applies to the patient scenario and following these steps: o Enter patient details regarding bleed and stroke risk factors as prompted in the selected tool o View individualized guidance on the advice screen o Email a summary of the advice • Use the Quick Reference section to access supporting information and details such as "Guidance for Administering Reversal Agents” and “Components of the Clinician-Patient Discussion." Information in the app is derived from ACC’s Expert Consensus Decision Pathways on Periprocedural Management and Bleed Management in patients with AFib. The information and recommendations in this clinical decision support tool are meant to support clinical decision making. The app is not meant to and should not replace clinical judgement. The healthcare provider is in control of all diagnoses and other clinical decisions.
Screenshots
Verdict
InpharmD and ManageAnticoag both sit at 4.9 stars, but that hides the real split: 100% of ManageAnticoag's written reviews are positive against 60% of InpharmD's. ManageAnticoag also leads on ads (none vs shown) and monetization model (free vs free with in-app purchases). InpharmD's advantage is update cadence (every 5 weeks vs every 23 months) and ratings volume (159 vs 7). On price, rating, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 4.9 for InpharmD against 4.9 for ManageAnticoag. That said, the two scores are not equally well evidenced: InpharmD has 159 ratings behind it against 7, so its average is the more settled of the two. Written reviews are what separate them: 60% of InpharmD's written reviews are positive against 100% of ManageAnticoag's.
InpharmD ships an update every 5 weeks, ManageAnticoag every 23 months. The most recent releases landed on October 23, 2026 and October 26, 2026 respectively.
| Parameter | InpharmD | ManageAnticoag |
|---|---|---|
| Price | Free | Free |
| Rating | 4.9 (159 ratings) — better | 4.9 (7 ratings) |
| Positive reviews | 60.0% of reviews | 100.0% of reviews — better |
| Number of ratings | 159 — better | 7 |
| Update frequency | Every 5 weeks — better | Every 23 months |
| Ads | Yes | No — better |
| In-app purchases | No | No |
| Monetization | Free with in-app purchases | Free — better |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 18.0 | 13.0 — better |
| Further details — not scored | ||
| Size | 47 MB | 34 MB |
| Age rating | 17+ | 17+ |
| Developer | InpharmD, LLC | American College of Cardiology |
Customer experience
InpharmD
ManageAnticoag
In-app purchases
InpharmD
No in-app purchases
ManageAnticoag
No in-app purchases
Questions
Is InpharmD free?
Is ManageAnticoag free?
Which has better reviews, InpharmD or ManageAnticoag?
Do InpharmD or ManageAnticoag have ads?
Which is updated more often, InpharmD or ManageAnticoag?
Other comparisons















